EBITDA Margin ratio Analysis of Dr. Reddy’s Laboratories Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Mar-24
Very Good EBITDA Margin
29.03
Period Ending - Mar-23
Very Good EBITDA Margin
30.26
Growth
-4.07 %
Trailing Twelve Months EBITDA Margin
Period Ending - Mar-24
Very Good EBITDA Margin
25.86
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Good EBITDA Margin
26.12
EBITDA Margin Analysis of Dr. Reddy’s Laboratories Ltd.
| Ebitda Margin Ratio of Dr. Reddy’s Laboratories Ltd. with value of 25.86 means that its operating expenses are lower in relation to total revenue in trailing twelve months. |
| Ebitda Margin Ratio of Dr. Reddy’s Laboratories Ltd. with value of 26.12 means that its operating expenses are lower in relation to total revenue latest Quarter ending on Mar-24. |
| EBITDA Margin Ratio of RDY has fallen by -4.07 % Compared to previous Financial Year. |
| EBITDA Margin Ratio with value of 30.26 was highest in Year Mar-23 in last Five Years. |
| EBITDA Margin Ratio with value of 21.03 was lowest in Year Mar-22 in last Five Years. |
| Latest EBITDA Margin Ratio with value of 29.03 is Greater than Average EBITDA Margin of 26.89 in last five years. |
Other EBITDA Margin Related Info of RDY that may interest you.
Dr. Reddy’s Laboratories Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| RDY | 71.7 | 71.85 | 0.209 % | Drug Manufacturers-Specialty & Generic |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| No Significant Profitability | |
FY - Historical EBITDA Margin of Dr. Reddy’s Laboratories Ltd.
| Period | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 |
|---|---|---|---|---|---|---|---|
| EBITDA Margin | 29.03 | 30.26 | 21.03 | 25.75 | 28.37 | 23.09 | 18.90 |
| Change | -4.07 % | 43.93 % | -18.35 % | -9.21 % | 22.86 % | 22.18 % | 0.168 % |
FY Chart of EBITDA Margin of Dr. Reddy’s Laboratories Ltd.
Note : All Data Generated at the End of Trading Hours (EOD Data)